High-risk prostate cancer: Value of multi-Modality 3T MRI-Guided biopsies after previous negative biopsies

Abdominal Imaging

Volumn 37, Issue 5, 2012, Pages 892-896

  Fütterer, Jurgen J ^a   Verma, Sadhna ^b   Hambrock, Thomas ^a   Yakar, Derya ^a   Barentsz, Jelle O ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Detection; MR imaging; MR guided biopsy; Prostate cancer

Indexed keywords

BIOPSY TECHNIQUE; CANCER DIAGNOSIS; ECHO PLANAR IMAGING; HEMATURIA; HEMOSPERMIA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATITIS; REVIEW; SUPINE POSITION; TRANSRECTAL ULTRASONOGRAPHY; TUMOR LOCALIZATION;

BIOPSY, NEEDLE; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 84868092273     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-011-9818-6     Document Type: Review

References (22)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2009. CA Cancer J Clin 60(5):277-300
2. Hricak H (2005) MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 78(2): S103-S111
3. Gilligan T, Kantoff PW (2002) Chemotherapy for prostate cancer. Urology 60:94-100
4. Thompson IM, Seay TM (1997) Will current clinical trials answer the most important questions about prostate adenocarcinoma? Oncology (Williston Park) 11:1109-1117
5. Thompson IM, Pauler DK, Goodman PJ, et al. (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level
6. Thompson IM, Ankerst DP, Chi C, et al. (2005) Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA 294:66-70
7. Gretzer MB, Partin AW (2003) PSA markers in prostate cancer detection. Urol Clin North Am 30:677-686
8. Canto EI, Singh H, Shariat SF, et al. (2004) Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection. J Urol 172:900-904
9. Singh H, Canto EI, Shariat SF, et al. (2004) Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol 171:1089-1092
10. Hambrock T, Fü tterer JJ Huisman HJ, et al. (2008) Thirty twochannel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: Technique and feasibility. Invest Radiol 43:686-694
11. Hoeks CMA, Barentsz JO, Hambrock T, et al. (2011) Prostate cancer: Multiparametric MR imaging for detection, localization, and staging. Radiology [Epub Ahead of Print].
12. Anastasiadis AG, Lichy MP, Nagele U, et al. (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50:738-748
13. Beyersdorff D, Winkel A, Hamm B, et al. (2005) MR imagingguided prostate biopsy with a closed MR unit at 1.5 T: Initial results. Radiology 234:576-581
14. Engelhard K, Hollenbach HP, Kiefer B, et al. (2006) Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol 16:1237-1243
15. Hambrock T, Somford DM, Hoeks C, et al. (2010) Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 183:520-527
16. Franiel T, Stephan C, Erbersdobler A, Dietz E, et al. (2011) Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding-multiparametric MR imaging for detection and biopsy planning. Radiology 259:162-172
17. Hara R, Jo Y, Fujii T, et al. (2008) Optimal approach for prostate cancer detection as initial biopsy: Prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology 71:191-195
18. Ingber MS, Ibrahim I, Turzewski C, Hollander JB, Diokno AC (2010) Does periprostatic block reduce pain during transrectal prostate biopsy? A randomized, placebo-controlled, double-blinded study. Int Urol Nephrol 42:23-27
19. Hambrock T, Somford DM, Huisman HJ, et al. (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and gleason grade in peripheral zone prostate cancer. Radiology 259:453-461
20. Mazaheri Y, Shukla-Dave A, Hricak H, et al. (2008) Prostate cancer: Identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 246:480-488
21. de Souza NM, Riches SF, Vanas NJ, et al. (2008) Diffusionweighted magnetic resonance imaging: A potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 63:774-782
22. Singh AK, Kruecker J, Xu S, et al. (2008) Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int 101:841-845